Download Autism - Current Theories and Evidence - A. Zimmerman (Humana, 2008) WW PDF

TitleAutism - Current Theories and Evidence - A. Zimmerman (Humana, 2008) WW
File Size10.4 MB
Total Pages479
Table of Contents
		Autism: Current Theories and Evidence
			Moving Beyond Hypotheses: A Call for Theories and Evidence
			Quotations from Leo Kanner
		List of Color Plates
	Part 1: Molecular and Clinical Genetics
	ENGRAILED2 and Cerebellar Development in the Pathogenesis of Autism Spectrum Disorders
			History of Autism
			ASD Neuropathology and Pathogenesis
		Cerebellar Development, Function, and ASD
			Cerebellar Development
			Postnatal Cerebellar Development
			Cerebellar Patterning Genes
			Patterning Gene Expression
			Combinatorial Gene Expression Confers Cell-Specific Identity
			Biochemical and Molecular Signals in Cerebellar Development
			Cerebellar Abnormalities in ASD
			Effects of Cerebellar Abnormalities in ASD
		Extracerebellar Functional Deficits in ASD
		En2 Transgenic Mice Phenocopy ASD Cerebellar Neuropathology
			Molecular Abnormalities in En2 Mutant Mice
			Overexpression of En2 also Results in ASD-Like Cerebellar Pathology
			Functional Deficits in En2 Mutant Mice
		ASD Genetic and Environmental Etiology
			Thalidomide and VPA
			Twin Studies in ASD
			Rett Syndrome and Epigenetic Regulation
			Genes of Interest in ASD
			Endophenotypes and ASD Genes
		ENGRAILED-2 is an Autism-Associated Gene
		En2 Function During Cerebellar Development
		Preliminary Data
			En2 and IGF-1
	Teratogenic Alleles in Autism and Other Neurodevelopmental Disorders
		Approaches to Documenting Action of a Teratogenic Allele
		Examples of Teratogenic Alleles
			Documentation of a Teratogenic Allele by Maternal Transmission Disequilibrium Test
				MTR*2756G and MTRR*66G as Teratogenic Alleles for Spina Bifida
				GSTP1*313A and GSTP1*341C as Teratogenic Alleles for Autism
			Documentation of a Teratogenic Allele by Maternal Transmission Disequilibrium Test Equivalent
				Maternal Phenylketonuria
				Rh Incompatibility
			Documentation of a Teratogenic Allele by the Log-Linear Method
				The MTHFD1*653Q Allele and Spina Bifida
				The CYP1A1*6235C Allele and Low Birth Weight
				NAT1 Alleles and Spina Bifida Risk
				The CCL-2*(-2518)A Promoter Allele and Spina Bifida Risk
			Documentation of a Teratogenic Allele by Regression Methods
				Maternal Alleles Influence Newborn Lipoprotein Concentrations
				Maternal GSTP1 Alleles and the Asthma Phenotype in Children
			Documentation of a Teratogenic Allele by Case-Control Methods Plus Case Transmission Disequilibrium Test
				Maternal MTHFR 677T Allele as a Risk Factor for Cleft Lip With or Without Cleft Palate (CL/P)
				Maternal MTHFR 677T Allele as a Risk Factor for Congenital Heart Disease
				Maternal MTHFR 677T Allele as a Risk Factor for Down Syndrome
				HLA-DR4 as a Risk Factor for Autism
			Suggestion of a Teratogenic Allele by Case-Control Methods Without Case Transmission Disequilibrium Test
				Complement C4B*0 and HLA-DR4 as Possible Teratogenic Alleles for Autism
				The GSTP1*1b Allele as a Possible Teratogenic Allele for Recurrent Early Pregnancy Loss
				The MTHFR*1298C Allele as a Possible Teratogenic Allele for Spina Bifida
				Methylenetetrahydrofolate Reductase (MTHFR)*677T and Methionine Synthase Reductase (MTRR)*66G as Possible Teratogenic Alleles for Down Syndrome
				Glutathione S-Transferase Deletion Allele (GSTT1*0) as a Possible Teratogenic Allele for Oral-Facial Clefting
				MTHFR*1298C as a Possible Teratogenic Allele for Spina Bifida
				The Glutathione S-Transferase Gene Deletion Allele, GSTM1*0, as a Possible Risk Factor for Recurrent Pregnancy Loss
				The Dihydrofolate Reductase 19-Basepair Deletion Allele, A Possible Teratogenic Allele for Spina Bifida
				The CYP1A1*2A Allele as a Possible Teratogenic Allele for Recurrent Pregnancy Loss
				The DHFR 19-bp Deletion Allele as a Possible Teratogenic Allele for Preterm Delivery
				The Methylenetetrahydrofolate Reductase (MTHFR)*1298C Allele as a Possible Teratogenic Allele for Down Syndrome
			Potential Examples of Teratogenic Alleles
			A Word About Mechanisms by Which Teratogenic Alleles Act
		Teratogenic Alleles and Autism
	Cholesterol Deficit in Autism: Insights from Smith-Lemli-Opitz Syndrome
		Cholesterol Pathways and SLOS
		Cholesterol-Related Mechanisms in ASD
		Treatment Approaches
	Autism in Genetic Intellectual Disability: Insights into Idiopathic Autism
			General Issues
			Background on Genetic Disorders Associated with Idiopathic Autism
				Fragile X Syndrome
				Down Syndrome
				Rett Syndrome
		Clinical and Behavioral Features of Genetic Disorders Associated With Autism: Implications for Idiopathic Autism or Autism Spectrum Disorders
			Autism in Fragile X syndrome: Deficit in Complex Social Interaction and Adaptive Socialization, with Severe Social Withdrawal but no Regression
			Autism in Down Syndrome: Complex and Simple Stereotypic Behaviors and High Prevalence of Regression
			Autism in Rett Syndrome: Preserved Communication and Motor Function With Regression
		Insights into the Neurobiology of Idiopathic Autism
			Neurobiology of Fragile X Syndrome and Autism Spectrum Disorder: Anomalies of the Cerebellar Vermis and Limbic Dysfunction
			Neurobiology of Down Syndrome and Autism Spectrum Disorders: Cerebellar Enlargement and Stereotypies
			MeCP2Deficiency and the Neurobiology of Autism Spectrum Disorders
		Genetic and Molecular Pathways Common to Autistic Disorders
			Molecular Basis of Fragile X Syndrome and Autism Spectrum Disorders: Cytoplasmic FMR1-Interacting Protein 1 and Other Downstream Fmrp Targets
			Molecular Basis of Down Syndrome and Autism Spectrum Disorders: Genes Involved in Early Brain Development
			Mecp2 Levels are Dysregulated in Idiopathic Autism Spectrum Disorders
		Concluding Remarks
	Part 2: Neurotransmitters and Cell Signaling
	Serotonin Dysfunction in Autism
		The Role of Serotonin in Cortical Development and Plasticity
		Neurotrophins, BDNF, and Serotonin
		Serotonin and Immune Activation
		Animal Models, Serotonin, and Autism
	Excitotoxicity in Autism: The Role of Glutamate in Pathogenesis and Treatment
		Excitotoxicity and Autism
			Evidence for Excitotoxicity in Autism
				Laboratory Findings
				Magnetic Resonance Spectroscopy
				Postmortem Data
				Immune Studies
				Relationship to Other Disorders
				Genetic Studies
		Implications for Treatment
	Prenatal b2-Adrenergic Receptor Signaling and Autism: Dysmaturation and Retained Fetal Function
		The b2-Adrenergic Receptor
			Regulation of b2-Adrenergic Receptor Signaling
			Polymorphisms of the b2-Adrenergic Receptor
		Animal Studies
		What is the Relationship to Autism?
		Relating the Model to Autism Research
			Neuroglial Activation
			Increased Cerebral White Matter
			Insulin-like Growth Factor-1
			Glial Fibrillary Acidic Protein, Bcl-2, and GAD67
			Sulfation, Methylation, and Oxidative Stress
			Plasma and Whole Blood Serotonin
			The Gastrointestinal Tract
			The Immune System
			The Autonomic Nervous System
			Differences in Signal Transduction
		Different Mechanisms, Similar Result
		Prenatal b2-Adrenergic Receptor Overstimulation and Sensitization to Other Factors
		Effects on Other Neurotransmitter Systems
		The Role of Maternal Factors
		Prenatal b2-Adrenergic Receptor Understimulation
	Part 3: Endocrinology, Growth, and Metabolism
	A Role for Fetal Testosterone in Human Sex Differences: Implications for Understanding Autism
		The Extreme Male Brain Theory of Autism
		Hormones and Sexual Differentiation
		Atypical Fetal Hormone Environments
			Congenital Adrenal Hyperplasia
			Complete Androgen Insensitivity Syndrome
			Idiopathic Hypogonadotropic Hypogonadism
		Hormonal Effects: Indirect Studies in Typical Populations
			Digit Ratio (2D:4D)
			Pubertal Onset
			Co-Twin Sex
		Hormonal Effects: Measurements of Fetal Testosterone
			Maternal Sampling During Pregnancy
			Samples from the Umbilical Cord
			Amniotic Fluid
			Cambridge Fetal Testosterone Project
				Fetal Testosterone and Eye Contact at 12 Months
				Fetal Testosterone and Vocabulary at 18 and 24 Months
				Fetal Testosterone and Empathy at Age 4
				Fetal Testosterone, Restricted Interests, and Social Relationships at Age 4
				Fetal Testosterone, Systemizing, Empathizing at Ages 6-8
				Behaviors Associated with ASC
				Fetal Testosterone and Autistic Traits
			Limitations of Amniocentesis Methods
	Interaction between Genetic Vulnerability and Neurosteroids in Purkinje cells as a Possible Neurobiological Mechanism in Autism Spectrum Disorders
		Organizing Role of Sex Hormones in Neuronal Growth and Survival
		Sex Steroids Regulate Neuronal Death and Survival
		The Loss of Cerebellar Purkinje Cells in ASD
		Estrogens Influence Cerebellar PC Growth, Maturation, and Survival
		The Male Heterozygous Reeler Mouse: A Possible Heuristic Model of Cerebellar Pathology in ASD
		Future Research Avenues
	Insulin-Like Growth Factors: Neurobiological Regulators of Brain Growth in Autism?
		What are Neurotrophic Factors?
		Insulin-Like Growth Factors
		Insulin-Like Growth Factors and Head Growth
		Insulin-Like Growth Factors and Specific Brain Cells
		Autism and Head Growth
		Studies on Autism and Neural Growth Factors
			The Finnish Study
				CSF IGF-1 and IGF-2 in Autism
				Serotonin and IGF
		Autism and Rett Syndrome
		Serum IGF-1
	Oxidative Stress and the Metabolic Pathology of Autism
			Oxidative Stress
			Glutathione and Redox Homeostasis
		Hypothesis and Evidence Linking Oxidative Stress and Autism
			Single Gene Disorders
			Prenatal and Peri-Natal Environmental Exposures
			Gender Disparity in Autism
			Clinical Pathology of Autism and Oxidative Stress
		Gene-Environment Interactions Affecting Glutathione and Redox Imbalance
			Pro-Oxidant Environmental Exposures
			Oxidative Stress During Neurodevelopment
			Genes, Environment, and the Autism Metabolic Phenotype
		Systemic Implications of Oxidative Stress and Autism Metabolic Pathology
			Autism Metabolic Phenotype
			Gut-Brain-Immune Connection Applied to Autism
		Future Prospects
	The Immune System in Autism: Is There a Connection?
		Autoantibodies in Autism Spectrum Disorder
		Maternal Antibodies to Fetal Brain
		Immune Dysfunction in Children with ASD
		Making the Final Connections
	Part 4: Immunology, Maternal-Fetal Interaction, and Neuroinflammation
	Maternal Immune Activation, Cytokines and Autism
		Introduction: Genes Versus Environment in Autism
		Environmental Factors in Autism
		Maternal Immune Activation: Poly(Inosine:Cytosine)
		Maternal Immune Activation: Lipopolysaccharide
		Maternal Immune Activation: Periodontal Bacteria
		Other Protocols of Immune Activation
		Maternal Immune Activation Elevates Cytokines in the Fetal Environment
		Pro/Anti-Inflammatory Balance Mediates Maternal Immune Activation Effects on the Fetus
		Cytokines and Autism
		Mechanisms of Cytokine Action and Potential Therapies
	Maternal Antibodies and the Placental-Fetal IgG Transfer Theory
		Supporting Evidence
			Circumstantial Evidence
				HLA Studies
				Maternal Influences
				Hygiene Hypothesis
				Clinical Examples of Maternal Antibodies Altering Fetal Human Development
			Direct Evidence
				Presence of Anti-Fetal Brain Antibodies in MCAD
				Association Between Presence of Maternal Antibodies Against Fetal Brain Tissue and Developmental Regression in Offspring with Autism
				Pregnant Dam (Mouse) Model
	Can Neuroinflammation Influence the Development of Autism Spectrum Disorders?
		Immune Responses and the Central Nervous System
		What is Neuroinflammation
		The Influence of Neuroimmune Responses in Brain Development
		Roles of Neuroglia During Brain Development
		Neurodevelopmental Roles of Cytokines and Chemokines
		Major Histocompatibility Complex and Complement Cascades in Brain Development and Synaptogenesis
		Neuroglia and Neuroimmune Responses During Adulthood
		Neuroglia and Synaptic Plasticity
		How May Neuroimmune Responses Influence the Pathogenesis of Autism Spectrum Disorders
		Maternal Factors in the Modulation of Neuroimmune Responses
		Chronic Neuroimmune Reactions in Autism Spectrum Disorder
		Genetic Susceptibility and Immune Responses in Neurological Disease
	Part 5: Neuroanatomy and Neural networks
	The Significance of Minicolumnar Size Variability in Autism: A Perspective from Comparative Anatomy
		Minicolumnar Pathology in Autism
			Methodological Considerations
			Trends for Between-Area Minicolumnar Variability
			Minicolumnar Variability Differences Between Species
			Functional Implications of Increased Minicolumnar Variability
	Imaging Evidence for Pathological Brain Development in Autism Spectrum Disorders
		Clinical Presentation
		Structural Imaging Relationships
		Magnetic Resonance Spectroscopy
		Testing models of apoptotic/synaptic pruning deficits in ASD
		Testing Models of Accelerated Brain Growth in ASD
	Information Processing, Neural Connectivity, and Neuronal Organization
		Complex Information Processing-Disconnectivity-Neuronal Organization Model of Autism
		Principles of Neurological Disorders
		General Principles of Developmental Neurobiologic Disorders
		Forming a Neurologically Based Model for Autism: Origins of Our Model
		Empiric Evidence for Our Model: Disordered Complex Information Processing
		Concept Formation: A Common Theme and Predictor of Underconnectivity with Frontal Cortex
		Visual Processing: Another Example of Generalized Integrative Processing Deficits
		A Dual-Task Experiment: Support for the Complex Information Processing Model
		Postural Control: Evidence of Abnormal Connectivity and Broad Involvement of the Brain
		The Neural Basis of Autism: The Origin of Functional Underconnectivity
		Disturbances in the Development of Neural Circuitry: A Second Disruption in Development
		Social Impairments in Autism
		Autism as a Disorder of Cortical Development
	Part 6: Environmental Mechanisms and Models
	Evidence for Environmental Susceptibility in Autism: What We Need to Know About Gene * Environment Interactions
		Developmental Neurotoxicants and Autism
			Cholinergic Agents
			Relevance to Autism
		Chemicals that Interfere with GABA Neurotransmission
			Relevance to Autism
		Chemicals that Interfere with Calcium Signalling
		Ca2+ and Neuronal Connectivity: How Chemicals can Make a Good Plan go Bad
	An Expanding Spectrum of Autism Models: From Fixed Developmental Defects to Reversible Functional Impairments
		Reflection on Autism Models
		From Behavioral to Multi-Leveled Nosology
			A Modular ‘‘Bottom-Up’’ Approach: Genes–Brain–Behavior
			The Critical Nature of Models and Diversity in Scientific Investigation
				Limits of a ‘‘Gene–Brain–Behavior’’ Model
			A Systems Pathophysiology ‘‘Middle-Out’’ Approach: Dysregulated Biology
				Analogies with multiple sclerosis
		Links Between Expanded Biological Hierarchy and Expanded Temporal Axis
			Delayed Onset of Autism
			Improvement and Recovery
		From a Static Defect in Early Circuit Development to a Chronic Ongoing Disturbance of Circuit Remodeling and Function
			A Model of Static Encephalopathy (Fig. 20.2)
			Genetic Static Encephalopathy (Fig. 20.2, Model 1a)
			Static Encephalopathy Caused by Gene-Environment Interactions (Fig. 20.2, Model 1b)
			A Model of Autism as a Chronic Condition (Fig. 20.2, Model 2)
				Epigenetic Contributors and Potential Plasticity (Fig. 20.2, Model 2a)
				Ongoing Environmental Contributors to Chronic Encephalopathy (Fig. 20.2, Model 2b)
				Autism as Trait vs. Autism as Trait Modulated by State vs. Autism as State
				Autism as Trait Modulated by State
				Autism as Predominantly State Rather than Trait
				Mistaking State for Trait
		Chronic Mechanisms in Functional Impairment in Autism
			Disturbances of Astroglial Function
			Neuronal and Neural Circuit Changes from Astroglial Metabolic and Structural Changes Deriving from Chronic Inflammation
			Release of Inhibitory and Excitatory Neuromodulators
			Retraction of Glial Processes
			Dismantling and Collapse of Synapses and Dendrites
			Glial Calcium Oscillations
			Sustaining Inflammation
			Summary of Glial Impacts: The Foregoing as Examples of New Classes of Mechanisms to Pursue
			Implications for Heterogeneity, Reversibility, Autism Symptoms, and Development–Chronicity Interactions
			The Challenge of Generic Mechanisms in a Specifically Described Disorder
		Summary and Conclusion
Document Text Contents
Page 2


Page 239

31. Belcher SM, Le HH, Spurling L, Wong JK. Rapid estrogenic regulation of extracellular
signal-regulated kinase 1/2 signaling in cerebellar granule cells involves a G protein- and
protein kinase A-dependent mechanism and intracellular activation of protein phospha-
tase 2A. Endocrinology 2005; 146: 5397–5406.

32. Singh M, Meyer E, Simpkins J. The effect of ovariectomy and estradiol replacement on
brain derived neurotrophic factor messenger ribonucleic acid expression in cortical and
hippocampal brain regions of female Sprague-Dawley rats. Endocrinology 1995; 136:

33. Sohrabji F, Miranda R, Toran-Allerand D. Identification of a putative estrogen response
element in the gene encoding brain-derived neurotrophic factor. Proc Natl Acad Sci USA
1995; 92: 11110–11114.

34. McMillan P, Singer C, Dorsa D. The effects of ovariectomy and estrogen replacement on
trkA and cholineacetyltransferase mRNA expression in the basal forebrain of the adult
female sprague-dawley rat. J Neurosci 1996; 16: 1860–1865.

35. Miranda R, Sohrabji F, Singh M, Toran-Allerand CD. Nerve growth factor (NGF)
regulation of estrogen receptors in explant cultures of the developing forebrain. J Neurobiol
1996; 31: 77–87.

36. ChaoMV, Hempstead B. p75 and Trk: A two-receptor system. Trends Neurosci 1995; 18:

37. Rabizadeh S, Oh J, Zhong L, Yang J, Bitler C, Butcher L, Bredesen D. Induction of
apoptosis by the low-affinity NGF receptor. Science 1993; 261: 345–348.

38. Majdan M, Lachance C, Gloster A, Aloyz R, Zeindler C, Bamji SX, Bhakar A,
Belliveau D, Fawcett J, Miller FD, Baker PA. Transgenic mice expressing the intracel-
lular domain of p75 neurotrophin receptor undergo neuronal apoptosis. J Neurosci
1997; 17: 6988–6998.

39. Sohrabji F, Miranda R, Toran-Allerand CD. Estrogen differentially regulates estrogen
and nerve growth factor receptor mRNAs in adult sensory neurons. J Neurosci 1994b; 14:

40. Toran-Allerand CD. Mechanisms of estrogen action during neural development: Media-
tion by interactions with the neurotrophins and their receptors? J Steroid Biochem Mol
Biol 1996; 56: 169–178.

41. Mendez P, Wandosell F, Garcia-Segura LM. Cross-talk between estrogen receptors and
insulin-like growth factor-I receptor in the brain: Cellular and molecular mechanisms.
Front Neuroendocrinol 2006; 27: 391–403.

42. Aguado F, Sanchez-Franco F, Cacidedo L, Fernandez T, Rodrigo J, Martinez-Murillo R.
Subcellular localization of insulin-like growth factor I (IGF-I) in purkinje cells of the adult
rat: An immunocytochemical study. Neurosci Lett 1992; 135: 171–174.

43. Bondy C, Werner H, Roberts CT Jr, LeRoith D. Cellular pattern of type-I insulin-like
growth factor receptor gene expression during maturation of the rat brain: Comparison
with insulin-like growth factors I and II. Neuroscience 1992; 46: 909–923.

44. Fukudome Y, Tabata T,Miyoshi T, Haruki S, Araishi K, Sawada S, KanoM. Insulin-like
growth factor-I as a promoting factor for cerebellar purkinje cell development. Eur J
Neurosci 2003; 17: 2006–2016.

45. Nordeen EJ, Nordeen KW. Estrogen stimulates the incorporation of new neurons into
the avian song nuclei during adolescence. Dev Brain Res 1989; 49: 27–32.

46. Ma ZQ, Spreafico E, Pollio G, Santagati S, Conti E, Cattaneo E, Maggi A Activated
estrogen receptor mediates growth arrest and differentiation of a neuroblastoma cell line.
Proc Natl Acad Sci USA 1993; 90: 3740–3744.

47. Rasmussen J, Torres-Aleman I, McLusky N, Naftolin F, Robbins R. The effects of
estradiol on the growth patterns of estrogen receptor-positive hypothalamic cell lines.
Endocrinology 1990; 126: 235–240.

48. Henderson RG, Brown AE, Tobet SA. Sex differences in cell migration in the preoptic
area/anterior hypothalamus of mice. J Neurobiol 1999; 41: 252–266.

226 F. Keller et al.

Page 240

49. Orikasa C, Kondo Y, Hayashi S, McEwen B, Sakuma Y. Sexually dimorphic expression
of estrogen receptor b in the anteroventral periventricular nucleus of the rat preoptic area.
Implication in luteinizing hormone surge. Proc Natl Acad Sci USA 2002; 99: 3306–3311.

50. Nordeen EJ, Nordeen KW, Sengelaub DR, Arnold AP. Androgens prevent normally
occurring cell death in a sexually dimorphic spinal nucleus. Science 1985; 229: 671–673.

51. Murakami S, Arai Y. Neuronal death in the developing sexually dimorphic periventri-
cular nucleus of the preoptic area in the female rat effect of neonatal androgen treatment.
Neurosci Lett 1989; 102: 185–190.

52. Davis EC, Popper P, Gorski RA. The role of apoptosis in sexual differentiation of the rat
sexually dimorphic nucleus of the preoptic area. Brain Res 1996; 734: 10–18.

53. Chung WC, Swaab DF, De Vries GJ. Apoptosis during sexual differentiation of the bed
nucleus of the stria terminalis in the rat brain. J Neurobiol 2000; 43: 234–243.

54. Breedlove SM, Arnold AP. Sexually dimorphic motor nucleus in the rat lumbar spinal
cord response to adult hormone manipulation, absence in androgen-insensitive rats.
Brain Res 1981; 225: 297–307.

55. Simerly RB, Zee MC, Pendleton JW, Lubahn DB, Korach KS. Estrogen receptor-
dependent sexual differentiation of dopaminergic neurons in the preoptic region of the
mouse. Proc Natl Acad Sci USA 1997; 94: 14077–14082.

56. DonCarlos LL, Handa RJ. Developmental profile of estrogen receptor mRNA in the
preoptic area of male and female neonatal rats. Dev Brain Res 1994; 79: 283–289.

57. Jordan CL, Breedlove SM, Arnold AP. Ontogeny of steroid accumulation in spinal
lumbar motoneurons of the rat implications for androgen’s site of action during synapse
elimination. J Comp Neurol 1991; 313: 441–448.

58. Freeman LM, Watson NV, Breedlove SM. Androgen spares androgen-insensitive moto-
neurons from apoptosis in the spinal nucleus of the bulbocavernosus in rats.Horm Behav
1996; 30: 424–433.

59. Forger NG, Howell ML, Bengston L, MacKenzie L, DeChiara TM, Yancopoulos GD.
Sexual dimorphism in the spinal cord is absent in mice lacking the ciliary neurotrophic
factor receptor. J Neurosci 1997; 17: 9605–9612.

60. Varela CR, Bengston L, Xu J, MacLennan AJ, Forger NG. Additive effects of ciliary
neurotrophic factor and testosterone on motoneuron survival; differential effects on
motoneuron size and muscle morphology. Exp Neurol 2000; 165: 384–393.

61. Merry DE, Korsmeyer SJ. Bcl-2 gene family in the nervous system. Annu Rev Neurosci
1997; 20: 245–267.

62. Zup SL, Carrier H, Waters E, Tabor A, Bengston L, Rosen G, Simerly R, Forger NG.
Overexpression of Bcl-2 reduces sex differences in neuron number in the brain and spinal
cord. J Neurosci 2003; 23: 2357–2362.

63. Forger NG, Rosen GJ, Waters EM, Jacob D, Simerly RB, de Vries GJ. Deletion of Bax
eliminates sex differences in the mouse forebrain. Proc Natl Acad Sci USA 2004; 101:

64. Jacob DA, Bengston CL, Forger NG. Effects of Bax gene deletion on muscle and
motoneuron degeneration in a sexually dimorphic neuromuscular system. J Neurosci
2005; 25: 5638–5644.

65. Garcia-Segura LM, Cardona-Gomez P, Naftolin F, Chowen JA. Estradiol upregulates
Bcl-2 expression in adult brain neurons. Neuroreport 1998; 9: 593–597.

66. Dubal DB, Shughrue PJ, Wilson ME, Merchenthaler I, Wise PM. Estradiol modulates
bcl-2 in cerebral ischemia a potential role for estrogen receptors. J Neurosci 1999; 19:

67. Bauman ML, Kemper TL. Histoanatomic observations of the brain in early infantile
autism. Neurology 1985; 35: 866–874.

68. Ritvo ER, Freeman BJ, Scheibel AB, Duong T, Robinson H, Guthrie D, Ritvo A. Lower
Purkinje cell counts in the cerebella of four autistic subjects: Initial findings of the UCLA-
NSAC autopsy research report. Am J Psychiatry 1986; 146: 862–866.

9 Interaction between Genetic Vulnerability and Neurosteroids 227

Page 478

Recurrent pregnancy loss (RPL) and
glutathione S-transferase (GST),

Reduced folate carrier 1 gene (RFC1), 44
Reelin (RELN) extracellular glycoprotein, 23
Retinoic acid response element (RARE),

regulator of HOX gene
expression, 21

Rett syndrome (RTT), 22–23, 82, 271
and Autism, 239–240

Serum IGF-1in, 241
MECP2 gene, 91

Rh Disease and fetal development, 313
Rh incompatibility disorders in fetus, 50
Rhombencephalon, 6
Risperidone, 5-HT2A-receptor antagonist,

Ryanodine receptors (RyR) in brain and

autism, 417
RyR-dependent mechanisms, neuronal

connectivity and synaptic
plasticity, 421–422

SAM/SAH methylation ratio, 246, 257, 258,

Schizophrenia, 289, 290, 292, 293, 298, 338
Selective serotonin reuptake inhibitors

(SSRIs), 112
Serotonin (5-hydroxytryptophan/5-HT),

neurotransmitter, 111–112
cortical development and plasticity,

and immune activation, 115–116
neurotrophins and, 114–115
Serotonin1A (5-HT1A) receptor, 76
serotonin system, dysfunction, 76
serotonin transporter (SERT) binding

capacity, 239
Sexually dimorphic nucleus of medial

preoptic area (SDNPOA), 211
Sib pair methods, 45. See also

Teratogenic alleles
Sjøgren’s syndrome, 276
SLC25A12 gene, 138
Smith-Lemli-Opitz syndrome (SLOS)

biochemical analyses for, 77
cholesterol pathways, 70–74
clinical diagnosis of, 70
defect in cholesterol synthesis, 75
7-DHC level and phenotypic

abnormalities, 70
facial features of, 71
phenotypic features of, 73

social and languagecommunication
impairments, 72

sterol abnormality associated with, 74–75
treatment approaches, 76–77
webbing and, 72

Sodium valproate, 140. See also Autism
Sonic hedgehog (Shh), extracellular growth

factors, 8
Spinal nucleus of bulbocavernosus (SNB),

Stromal-derived factor-1(SDF-1), 334
Superoxide dismutase (SOD1)

antioxidant enzymes, 160, 248
Synaptogenesis, 334–335
Syndactyly (webbing), 72
Systemic lupus erythematosus (SLE), 275,

Systemizing quotient (SQ), 186, 187, 198, 199

Tachykinin 1 (TAC1) gene, 139
Telencephalon of forebrain, 6
Teratogenic alleles, 42, 45

action mechanisms, 45–48, 62–63
and autism, 63
case-control methods plus case TDT,

maternal MTHFR 677T allele as
risk factor

CHD for, 54
for cleft lip with/ without cleft palate

(CL/P), 53–54
Down syndrome for, 54–55

case-control methods without case TDT
complement C4B*0 and HLA-DR4 as

alleles for autism, 56
CYP1A1*2A allele for recurrent

pregnancy loss, 60–61
DHFR 19-bp deletion allele as allele

for preterm delivery, 61
dihydrofolate reductase 19-basepair

deletion allele for spina bifida, 60
GSTM1*0 as risk factor for recurrent

pregnancy loss, 59–60
GSTP1*1b allele as allele for recurrent

early pregnancy loss, 56–57
GSTT1*0 as allele for Oral–Facial

Clefting, 58–59
MTHFR*1298C allele for Down

syndrome, 61–62
MTHFR*1298C allele for spina

bifida, 57, 59
MTHFR*677T and MTRR*66G as

alleles for Down syndrome, 58
case genetic effect, 47

Index 473

Page 479

Teratogenic alleles, 42, 45 (cont.)
log-linear method

CCL-2*(-2518)A promoter allele and
spina bifida risk, 52

CYP1A1*6235C allele and low birth
weight, 51

MTHFD1*653Q allele and spina
bifida, 51

NAT1 alleles and spina bifida risk,

maternal imprinting in, 46
maternal transmission disequilibrium test

GSTP1*313A and GSTP1*341C for
autism, 49

maternal phenylketonuria (PKU),

MTR*2756G and MTRR*66G for
spina bifida, 48–49

Rh incompatibility disorders, 50–51
regression methods

maternal alleles and newborn
lipoprotein concentrations, 52

maternal GSTP1 alleles and asthma
phenotype in children, 52–53

reports of, 43–44

B2AR agonist, 153–155
effect on ASD, 313

Tetrahydrofolate (THF)-dependent
methionine transmethylation and
glutathione synthesis, 247

Thalidomide and ASD susceptibility, 21
Timothy syndrome, 281
Tourette syndrome (TS), 275
Toxaphene usage and GABA

neurotransmission, 415
Tuberous sclerosis (TS) and autism, 251

Uterine natural killer (uNK) cells role in
pregnancy, 299

Valproic acid (VPA)
administration and ASD susceptibility,

anticonvulsant, 137
model for austism, 119–120

Velocardiofacial syndrome (VCFS), 82
Vesicular monoamine transporter

(VMAT2), 113
VZ-derived deep cerebellar nuclear

precursors, 11–12

Weschler Adult Intelligence Scale, 191

Zebrin II (aldolase-C), 14

474 Index

Similer Documents